Copeland Capital Management’s PetMed Express PETS Stock Holding History

Copeland Capital Management’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-755	Closed	-$19K	–	281
2022 Q1	$19K	Buy	755 +12	+2%	+$311	﹤0.01%	207
2021 Q4	$19K	Buy	743 +32	+5%	+$886	﹤0.01%	206
2021 Q3	$19K	Hold	711	–	–	﹤0.01%	203
2021 Q2	$23K	Hold	711	–	–	﹤0.01%	199
2021 Q1	$25K	Buy	711 +33	+5%	+$1.15K	﹤0.01%	192
2020 Q4	$22K	Buy	678 +15	+2%	+$462	﹤0.01%	185
2020 Q3	$21K	Buy	663 +236	+55%	+$7.81K	﹤0.01%	164
2020 Q2	$15K	Buy	+427	New	+$14.8K	﹤0.01%	184
2019 Q1	–	Sell	-434,886	Closed	-$10.1M	–	279
2018 Q4	$10.1M	Buy	434,886 +98,346	+29%	+$2.62M	0.72%	53
2018 Q3	$11.1M	Sell	336,540 -51,705	-13%	-$1.93M	0.67%	74
2018 Q2	$17.1M	Buy	388,245 +97,168	+33%	+$3.76M	1%	41
2018 Q1	$12.2M	Buy	+291,077	New	+$13.4M	0.78%	60

Other funds holding PETS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

Copeland Capital Management's PETS Position: Q2 2022 in Review

Copeland Capital Management sold out of PetMed Express (PETS) in Q2 2022, closing a stake of 755 shares — an estimated $19K sold.

Copeland Capital Management first reported a position in PETS in Q1 2018 and held it in 12 quarters. The position peaked at $17.1M in Q2 2018. 173 funds tracked by Wall St. Rank hold PETS as of Q2 2022.

Copeland Capital Management reported no remaining PetMed Express position as of Q2 2022 after selling out during the quarter.
Copeland Capital Management sold 755 PetMed Express shares in Q2 2022, an estimated $19K.
Copeland Capital Management first reported a position in PetMed Express in Q1 2018 and held it in 12 quarters.
Copeland Capital Management's PetMed Express position peaked at $17.1M in Q2 2018.
173 funds tracked by Wall St. Rank held PetMed Express as of Q2 2022.

Based on Copeland Capital Management's 13F filing for Q2 2022, filed 15 Jul 2022.